CT system

The US Food and Drug Administration (FDA) has granted 510(k) clearance for GE Healthcare‘s Discovery IQ PET/CT system.

GE Healthcare said that the new system can image with both half the Positron emission tomography (PET) dose and half the scan time.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The new system with Q.Clear technology has been developed to provide accurate quantitation (SUVmean) with better image quality (SNR) for small lesion detection, fast and efficient reading, and a confident diagnosis.

Compared with other PET/CT equipment, the new system is designed to offer National Electrical Manufacturers Association (NEMA) sensitivity up to 22cps/kBq, and axial field-of-view up to 26cm.

"By making Discovery IQ mobile-ready, we engineered it to be accessible to more patients in more places, allowing for high-performance PET/CT clinical care to whoever needs it."

GE Healthcare PET/CT general manager Wei Shen said: "By 2020, it’s estimated that 50% of people will develop cancer at some point in their lives and we also know that currently, approximately 70% of cancer patients do not respond to their initial chemotherapy treatment.

See Also:

"I’m excited about the recent FDA clearance of Discovery IQ, which will help physicians achieve their primary mission of delivering the best possible patient outcomes.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"And by making Discovery IQ mobile-ready, we engineered it to be accessible to more patients in more places, allowing for high-performance PET/CT clinical care to whoever needs it."

The new Q.Clear technology delivers no trade-off between image quality and quantitative SUV measurements.

The company said that the new system provides benefits to physicians across the cancer care continuum from diagnosis and staging to treatment planning and assessment.

Image: GE Healthcare’s Discovery IQ PET/CT system. Photo: courtesy of General Electric.